论文部分内容阅读
目的：比较地尔硫与丹参注射液静脉滴注（静滴）治疗冠心病的疗效。方法：冠心病８６例分为２组，地尔硫组４６例（男性２９例，女性１７例；年龄６２ａ±ｓ９ａ）用地尔硫注射液５０ｍｇ加入５％葡萄糖注射液２５０ｍＬ中静滴，ｑｄ×１０ｄ；丹参组４０例（男性２７例，女性１３例；年龄５８ａ±８ａ）用丹参注射液１６ｍＬ加入５％葡萄糖注射液２５０ｍＬ中静脉滴注，ｑｄ×１０ｄ。结果：地尔硫组与丹参组症状总有效率分别为６１％与３８％（Ｐ＜０．０１）；心电图总有效率分别为６１％与２８％（Ｐ＜０．０１）。地尔硫组对表示心肌缺血范围和程度的ＮＳＴ，ΣＳＴ及左室功能的ＳＶ，ＣＯ，ＥＦ改善均有显著意义（Ｐ＜０．０５），丹参组则无。结论：地尔硫治疗冠心病优于丹参。
Objective: To compare the efficacy of diltiazem and Salvia miltiorrhiza injection intravenously (intravenous infusion) in the treatment of coronary heart disease. Methods: Coronary heart disease (86 cases) was divided into 2 groups. Forty-six patients (29 males and 17 females; age 62a ± s9a) were treated with diltiazem injection 50mg in 250mL 5% dextrose injection, qd × 10d; Danshen group of 40 patients (27 males and 13 females; age 58a ± 8a) with Danshen injection 16mL added 5% glucose injection 250mL intravenous infusion, qd × 10d. Results: The total effective rates of Diltiazem group and Danshen group were 61% and 38%, respectively (P <0.01). The total effective rate of ECG was 61% and 28% respectively (P <0.01). Diltiazem group had significant effects on improvement of NST, ΣST and SV, CO, EF of myocardial infarction (P <0.05), but no in Danshen group. Conclusion: Diltiazem treatment of coronary heart disease is better than Salvia.